Pharmacokinetics and pharmacodynamics of the DPP-4 inhibitor, LAF237, in patients with type diabetes.

被引：0
|
作者：
He, YL [1 ]
Balch, A [1 ]
Campestrini, J [1 ]
Rivere, GJ [1 ]
Serra, D [1 ]
Prasad, P [1 ]
Ligueros-Saylan, M [1 ]
机构：
[1] Novartis Pharmaceut, NIBR, Cambridge, MA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2005年 / 77卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P56 / P56
页数：1
相关论文
共 50 条
  • [41] Comparison of the novel Russian DPP-4 inhibitor gosogliptin with vildagliptin in patients with type 2 diabetes mellitus
    Galstyan, K. O.
    Nedosugova, L., V
    Petunina, N. A.
    Trakhtenberg, J. A.
    Vostokova, N. V.
    Karavaeva, O., V
    Chasovskaya, T. E.
    DIABETES MELLITUS, 2016, 19 (01): : 89 - 96
  • [42] A comparison of effects of DPP-4 inhibitor and SGLT2 inhibitor on lipid profile in patients with type 2 diabetes
    Cha, Seon-Ah
    Park, Yong-Moon
    Yun, Jae-Seung
    Lim, Tae-Seok
    Song, Ki-Ho
    Yoo, Ki-Dong
    Ahn, Yu-Bae
    Ko, Seung-Hyun
    LIPIDS IN HEALTH AND DISEASE, 2017, 16 : 1 - 8
  • [43] A comparison of effects of DPP-4 inhibitor and SGLT2 inhibitor on lipid profile in patients with type 2 diabetes
    Seon-Ah Cha
    Yong-Moon Park
    Jae-Seung Yun
    Tae-Seok Lim
    Ki-Ho Song
    Ki-Dong Yoo
    Yu-Bae Ahn
    Seung-Hyun Ko
    Lipids in Health and Disease, 16
  • [44] Cost and clinical impact of a nonmedical DPP-4 inhibitor switch in patients with diabetes
    Kheloussi, Steven
    Johns, Alicia
    Parente, Vincenzo
    McLay, William
    Gionfriddo, Michael R.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (07): : 846 - 854
  • [45] Sitagliptin: Profile of a novel DPP-4 inhibitor for the treatment of type 2 diabetes (update)
    Gallwitz, Baptist
    DRUGS OF TODAY, 2007, 43 (11) : 801 - 814
  • [46] Discovery of Imigliptin, a Novel Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes
    Shu, Chutian
    Ge, Hu
    Song, Michael
    Chen, Jyun-hong
    Zhou, Huimin
    Qi, Qu
    Wang, Feng
    Ma, Xifeng
    Yang, Xiaolei
    Zhang, Genyan
    Ding, Yanwei
    Zhou, Dapeng
    Peng, Peng
    Shih, Cheng-kon
    Xu, Jun
    Wu, Frank
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (08): : 921 - 926
  • [47] The DPP-4 inhibitor vildagliptin: robust glycaemic control in type 2 diabetes and beyond
    Panina, G.
    DIABETES OBESITY & METABOLISM, 2007, 9 : 32 - 39
  • [48] Erratum to: Saxagliptin: a New DPP-4 inhibitor for the treatment of type 2 diabetes mellitus
    Abd A. Tahrani
    Milan K. Piya
    Anthony H. Barnett
    Advances in Therapy, 2009, 26 : 736 - 736
  • [49] A NOVEL ONCE-WEEKLY DPP-4 INHIBITOR IN THE CARE OF TYPE 2 DIABETES
    Grigorescu, Elena-Daniela Dediu
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2016, 120 (03): : 603 - 603
  • [50] Evaluation of drug efficacy of DPP-4 inhibitors based on theoretical analysis with pharmacokinetics and pharmacodynamics
    Takayanagi, Risa
    Uchida, Takumi
    Kimura, Koji
    Yamada, Yasuhiko
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2017, 38 (04) : 273 - 279
12345